Clinical Trial Update: A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE) [Phase 2]

View source ↗

Summary

This Phase 2 study (LUTE) of Lebrikizumab in patients with asthma uncontrolled with inhaled corticosteroids and a second controller has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Lebrikizumab (lebrikizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED